Name	Short Description	Data Source
Global Unique Device Identification Database (GUDID)	The Global Unique Device Identification Database (GUDID) contains key device identification information submitted to the FDA about medical devices that have Unique Device Identifiers (UDI).	FDA
Medicare NCCI Medically Unlikely Edits (MUEs)	National Correct Coding Initiative (NCCI) Medically Unlikely Edits (MUEs) are used by the Medicare Administrative Contractors (MACs), to reduce improper payments for Part B claims.	CMS
Medicaid Drug Rebate Program Data	Product data for drugs in the Medicaid drug rebate program.	CMS
FDA Unique Ingredient Identifiers (UNIIs)	FDA’s Global Substance Registration System enables efficient and accurate exchange of information on substances through their Unique Ingredient Identifiers (UNIIs) which can be generated at any time in the regulatory life cycle.
OpenFDA Human NDC Directory		FDA
FDA Compounded Drugs		NLM
Medicaid Utilization		CMS
ACA FUL (Federal Upper Limit)	https://www.medicaid.gov/medicaid/prescription-drugs/pharmacy-pricing/index.html	CMS
Alabama Average Acquisition Cost (AAC)		Alabama Medicaid Agency
Texas Formulary Drug File (340B Pricing)		Texas HHS
NDC/NHRIC Labeler Codes	This is a list of NDC/NHRIC Labeler Codes which have been electronically submitted.	FDA
CMS Drug Spending		CMS
FAERS Adverse Event Reports		FDA
REMS		FDA
503B		FDA
Medicaid Covered Outpatient Prescription Drug Reimbursement Information by State		CMS
ASHP Drug Shortages		ASHP
Drug Interactions	Get the drug interactions for a specified drug.	NLM
CMS Formulary		CMS
DailyMed Indexing and REMS Files		NLM
Medicaid Drug Rebate Program - New/Reinstated and Terminated Labeler Information		CMS
FDA NDC SPL Data Elements (NSDE)		FDA
SEER*Rx		NCI
PrimeKG		Harvard University
Dietary Supplement Fact Sheets		Office of Dietary Supplements
LiverTox		NIDDK
CMS Alpha-Numeric HCPCS	These files contain the Level II alphanumeric HCPCS procedure and modifier codes, their long and short descriptions, and applicable Medicare administrative, coverage and pricing data.	CMS
Remittance Advice Remark Codes	Remittance Advice Remark Codes (RARCs) are used to provide additional explanation for an adjustment already described by a Claim Adjustment Reason Code (CARC) or to convey information about remittance processing.	X12
Claim Adjustment Reason Codes	These codes describe why a claim or service line was paid differently than it was billed.	X12
Therapeutic Target Database		Bioinformatics and Drug Design Group (BIDD)
Drug Establishments Current Registration Site	The drug establishments current registration site is a publication of currently registered establishments which manufacture, prepare, propagate, compound or process drugs that are distributed in the U.S. or offered for import to the U.S.	FDA
Wholesale Distributor and Third-Party Logistics Providers	The Drug Supply Chain Security Act (DSCSA) requires wholesale distributors and third-party logistics providers to report licensure and other information to FDA annually.	FDA
Medicare Advantage / Part D Contract and Enrollment Data	The Medicare Advantage (MA) / Part D Contract and Enrollment Data section serves as a centralized repository for publicly available data on contracts and plans, enrollment numbers, service area data, and contact information for MA, Prescription Drug Plan (PDP), cost, PACE, and demonstration organizations.	CMS
ATC DDD Codes		WHO
VG Codes		CDC
CVX Codes		CDC
PubChem		NLM
LactMed		NLM
Global Substance Registration System (GSRS)		NCATS
USP Medicare Model Guidelines		USP
Pharmaceutical Benefits Scheme (PBS)		Australian Government
Canadian Drug Ontology		Canadian Government
UK Teratology Information Service		UK Government
Australian Pregnancy Categories		Australian Government
Australian Drug Labels		Australian Government
Dietary Supplement Ingredient Database (DSID)		Office of Dietary Supplements
DrugCentral		University of New Mexico
Australian Non-Prescription Medications		Australian Government
Dietary Supplement Label Database (DSLD)		Office of Dietary Supplements
Canada Drug Product Database (DPD)		Canadian Government
Canada Vigilance Adverse Reaction Database		Canadian Government
European Public Assessment Reports (EPAR)		European Medicines Agency (EMA)
MedlinePlus		NLM
CMS I/OCE		CMS
EMA Shortages		European Medicines Agency (EMA)
SIDER	SIDER contains information on marketed medicines and their recorded adverse drug reactions.	Biobyte Solutions
DDInter	DDInter is a comprehensive, professional, and open-access database specific to drug-drug interactions.	CBDD Group

‣

Doing

Name	Short Description	Data Source
DailyMed	FDA structured product label (SPL) information archived in XML format by NLM.	NLM

‣

Done

Name	Short Description	Data Source
RxNorm Full	This is the full RxNorm monthly data release. Requires (free) UMLS license.	NLM
RxTerms	RxTerms is a drug interface terminology derived from RxNorm for prescription writing or medication history recording (e.g. in e-prescribing systems, PHRs).	NLM
FDA NDC Directory	Product listing data submitted for all finished drugs including prescription and over-the-counter drugs, approved and unapproved drugs and repackaged and relabeled drugs.	FDA
FDA Excluded	Products removed / excluded from the NDC Directory for failure to respond to FDA’s requests for correction for various reasons.	FDA
FDA Unfinished	Product listing data submitted for all unfinished drugs, including active pharmaceutical ingredients, drugs for further processing and bulk drug substances for compounding.	FDA
NADAC	Identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act) and related patent and exclusivity information.	CMS
Medicare Part D Prescription Drug Plan Formulary, Pharmacy Network, and Pricing Information	Formulary, pharmacy network, and pricing data for Medicare Prescription Drug Plans and Medicare Advantage (MA) Prescription Drug Plans (with the exception of employer and Program of All-Inclusive Care for the Elderly plans).	CMS
Orange Book	Drug products with therapeutic equivalence evaluations approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act) and related patent and exclusivity information.	FDA
Purple Book	Information about all FDA-licensed biological products regulated by CDER, including licensed biosimilar and interchangeable products, and their reference products, and FDA-licensed allergenic, cellular and gene therapy, hematologic, and vaccine products regulated by CBER.	FDA
FDA Enforcement Reports (Recalls)	FDA recalls.	FDA
DailyMed Mapping Files		NLM
RxClass ATC to Product RXCUI	Also known as ATCPROD. ATC4 codes to product RXCUIs as mapped by NLM.	NLM
RxNorm Historical	Historical NDCs mapped to product RXCUIs with start and end dates and indirect RXCUI linkages.	NLM

‣

Requested

Name	Short Description	Data Source
Drugs@FDA		FDA
Value Set Authority Center (VSAC)		NLM

Request new data source

Don’t see what you’re looking for on this list?

✋ Request new data source

← Previous

Data sources

Staging data

On this page

Source data
Request new data source